Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cybin Inc N.CYBN

Alternate Symbol(s):  CYBN

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary... see more

Bullboard (NEO:CYBN)

View:
Comment by superzoomer710on Nov 13, 2020 11:28am

RE:RE:RE:I like it

Something just doesn't smell right here, a stock with this much apparent push would have heavy volume in the first weeks. A couple of LOI’s smishhhhhhhhh Provisional patents smishhhhhh. The ...more  
Post by CBDANDMEon Nov 13, 2020 9:20am

SEDI

Multiple SEDI reports filed. options, warrants, and common shares.
Comment by 88guy88on Nov 12, 2020 2:19pm

RE:RE:I like it

phase2 is planned for early 2021....that is hardly "miles away" or "kilometers away"...Canadian eh.....the management team is solid and all cashed up.....let er rip!
Comment by superzoomer710on Nov 12, 2020 2:11pm

RE:I like it

form the deck and LS this  is miles away do they have an IND or Pre IND or DIN# on any of these products, 45 million is great...... the team on this, i can only think huge burn rate
Comment by CBDANDMEon Nov 12, 2020 1:09pm

RE:I like it

Also pretty low float!
Post by 88guy88on Nov 12, 2020 12:11pm

I like it

Raised 45 million pre public market.....so nicely cashed up.....phase 2 trials in ealy 2021 only a couple of months away....focus on sublingual dose so it has more immediate effect rather than pill ...more  
Post by superzoomer710on Nov 12, 2020 10:47am

why is this .89

Can anyone tell me what Cybiin has??????????
Comment by realitycheck00on Nov 11, 2020 12:09am

RE:RE:RE:Shrim

I beleive around 130m from the last deck I saw.
Comment by pp19888on Nov 10, 2020 4:24pm

RE:RE:Shrim

Added today, was expecting to open 2 but when I seen under a dollar went all in. 
Comment by CBDANDMEon Nov 10, 2020 3:25pm

RE:RE:Shrim

How many outstanding shares in this company. 60 mill?
Comment by realitycheck00on Nov 10, 2020 3:21pm

RE:Shrim

$45M raised on pre-public!  Not too shabby - nice little warchest for M&A
Post by TheTanManon Nov 10, 2020 1:47pm

Shrim

Schwing
Comment by EDMINNEMAon Nov 06, 2020 9:23am

RE:A big scandal might be unfolding in Canadian markets

THERE ARE HUGE SCANDALS IN EVERY MARKET, OTC MARKETS IN THE USA THE WORSE
Post by SHeditorialon Sep 30, 2020 1:06pm

Early-stage psychedelics market is exploding...

And only going up... https://stockhouse.com/news/newswire/2020/09/29/this-company-illustrates-exactly-why-psilocybin-market-exploding
Post by SHeditorialon Sep 29, 2020 6:56pm

'Mushrooming' sector and opportunity

https://stockhouse.com/opinion/interviews/2020/09/22/a-psychedelic-nutraceutical-opportunity-a-boost-for-brain-and-your-portfolio
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities